News

CATL’s 6.7 per cent discount to its Shenzhen-traded shares is much lower than the average 25 per cent discount for ...
Shares of the restaurant chain began trading at HK$7.19 per share, unchanged from the offer price, before plunging 7 per cent ...
Chinese pharmaceutical group Jiangsu Hengrui Pharmaceuticals (SHE: 600276) is set to raise up to HK$9.89 billion ($1.27 ...
Chinese biotech company Bliss Biopharmaceutical (BlissBio) is reportedly considering a Hong Kong initial public offering (IPO ...
As firms line up to enter Hong Kong's market for initial public offerings, estimates suggest the city may rank among the top three global venues this year Hong Kong's market for initial public ...
Auntea Jenny is the latest of a string of tea companies to list in Hong Kong, just this year. Emily Tan takes a closer look at that market action.
Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...
The China-based casual dining brand began trading its IPO after pricing its 168,364,000 shares at HKD 7.19 per share.
Hesai Group, a Chinese lidar sensor maker, has discreetly filed for an IPO in Hong Kong. The stock is trading higher and has seen a 58% surge in the last 30 days.
Chinese restaurant operator Green Tea Group Limited, backed by Swiss private equity (PE) firm Partners Group, marked its debut on the main board of the Hong Kong stock exchange on Friday following its ...
Chinese AI drug developer METiS Pharmaceuticals is preparing for a Hong Kong initial public offering that could raise up to $200 million, highlighting the ongoing surge of investment in artificial ...
Minority owner Partners Group say the IPO proceeds will be used to further grow the Hangzhou-headquartered restaurant's ...